Fort Washington Investment Advisors Inc Edwards Lifesciences Corp Transaction History

Fort Washington Investment Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $160,544 - $238,069	-1,856 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$101.96 - $128.34 $189,237 - $238,199	1,856 New	1,856 $218,000
Q3 2021 Nov 09, 2021	SELL	$102.91 - $122.75 $1.01 Million - $1.2 Million	-9,797 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $459,176 - $597,564	-6,834 Reduced 41.09%	9,797 $782,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $956,947 - $1.28 Million	16,631 New	16,631 $1.15 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.